Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
As of 2026-05-03, Phathom Pharmaceuticals Inc. (PHAT) is trading at $12.01, marking a 7.23% gain in recent trading sessions. This analysis outlines key market context, technical support and resistance levels, and potential near-term scenarios for the stock, without offering investment advice. No recent earnings data is available for PHAT as of this date, so recent price movement has been driven largely by short-term trading flows and broader sector sentiment rather than quarterly financial perfo
Why Phathom Pharmaceuticals (PHAT) might be the steady performer you need (Investor Interest) 2026-05-03 - Crowd Entry Points
PHAT - Stock Analysis
4012 Comments
1774 Likes
1
Meraki
Loyal User
2 hours ago
This feels like I just unlocked confusion again.
👍 142
Reply
2
Vel
New Visitor
5 hours ago
Who else is trying to figure this out step by step?
👍 189
Reply
3
Calum
Trusted Reader
1 day ago
That’s pure artistry. 🎨
👍 57
Reply
4
Phineus
Consistent User
1 day ago
Comprehensive US stock backtesting and historical performance analysis to validate investment strategies before committing capital. We provide extensive historical data that allows you to test any trading idea before risking real money.
👍 250
Reply
5
Dejaneira
Expert Member
2 days ago
That deserves a gold star.
👍 74
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.